Home Cart Sign in  
Chemical Structure| 644-62-2 Chemical Structure| 644-62-2

Structure of Meclofenamic acid
CAS No.: 644-62-2

Chemical Structure| 644-62-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Meclofenamic acid is a balanced COX-1/COX-2 inhibitor and a non-selective gap junction blocker.

Synonyms: Meclofenamate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Meclofenamic acid

CAS No. :644-62-2
Formula : C14H11Cl2NO2
M.W : 296.15
SMILES Code : O=C(O)C1=CC=CC=C1NC2=C(Cl)C=CC(C)=C2Cl
Synonyms :
Meclofenamate
MDL No. :MFCD00072053

Safety of Meclofenamic acid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P264-P270-P301+P312-P330-P501

Related Pathways of Meclofenamic acid

epigenetics
cytoskeleton

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HeLa cells 80 and 120 μM 24 hours To investigate the effect of meclofenamic acid on m6A modification levels in HeLa cells. Results showed that meclofenamic acid treatment significantly increased m6A modification levels. Nucleic Acids Res. 2015 Jan;43(1):373-84.
GFAP-expressing cells 100 μM MFA, as a gap junction blocker, increased noise and reduced GABA current amplitudes while increasing input resistance without affecting the series (access) resistance. Nat Neurosci. 2005 Sep;8(9):1179-87.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Brain metastasis model Intraperitoneal injection 20 mg/kg/day Daily Meclofenamate inhibited the growth of brain metastases Nature. 2016 May 26;533(7604):493-498

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02429570 Recurrent Brain Metastases|Pro... More >>gressive Brain Metastases Less << ACTIVE_NOT_RECRUITING 2025-04-25 Baptist Health South Florida, ... More >>Miami, Florida, 33143, United States|Memorial Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, 07748, United States|Memorial Sloan Kettering Cancer Center at Commack, Commack, New York, 11725, United States|Memorial Sloan Kettering Westchester, Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Lehigh Valley Health Network, Allentown, Pennsylvania, 18103, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.38mL

0.68mL

0.34mL

16.88mL

3.38mL

1.69mL

33.77mL

6.75mL

3.38mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories